{"entity":{"type":"insider","cik":"0001727317","url":"/insider/0001727317","json_url":"/insider/0001727317.json","name":"Chivukula Pad","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":32,"n_filings":31,"first":"2020-09-04","last":"2024-10-16","span_basis":"filed_date"},"name_variants":[{"name":"Chivukula Pad","source":"filing","n_filings":31,"first_seen":"2020-09-04","last_seen":"2024-10-16"}],"transactions":[{"id":3170008,"accession":"0001193805-24-001248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-24-001248","line_url":"/filing/0001193805-24-001248#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":20.7601,"price_display":"20.76","price_state":"stated","total_value":249121.2,"total_display":"249,121.20","total_whole":"249,121","shares_owned_after":435334.0,"shares_owned_after_display":"435,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-15","filed_date":"2024-10-16","scope":"insider"},{"id":2382110,"accession":"0001193805-24-000768","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-24-000768","line_url":"/filing/0001193805-24-000768#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":114.0,"shares_display":"114","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":5130.0,"total_display":"5,130.00","total_whole":"5,130","shares_owned_after":447334.0,"shares_owned_after_display":"447,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-05","filed_date":"2024-06-07","scope":"insider"},{"id":2937999,"accession":"0001193805-24-000746","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-24-000746","line_url":"/filing/0001193805-24-000746#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26000.0,"shares_display":"26,000","price_per_share":40.009,"price_display":"40.01","price_state":"stated","total_value":1040234.0,"total_display":"1,040,234.00","total_whole":"1,040,234","shares_owned_after":447448.0,"shares_owned_after_display":"447,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-04","scope":"insider"},{"id":3169961,"accession":"0001193805-24-000452","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-24-000452","line_url":"/filing/0001193805-24-000452#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17435.0,"shares_display":"17,435","price_per_share":35.02,"price_display":"35.02","price_state":"stated","total_value":610573.7,"total_display":"610,573.70","total_whole":"610,574","shares_owned_after":473448.0,"shares_owned_after_display":"473,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-25","filed_date":"2024-03-27","scope":"insider"},{"id":2213420,"accession":"0001193805-24-000426","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-24-000426","line_url":"/filing/0001193805-24-000426#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8565.0,"shares_display":"8,565","price_per_share":35.0075,"price_display":"35.01","price_state":"stated","total_value":299839.2375,"total_display":"299,839.24","total_whole":"299,839","shares_owned_after":490883.0,"shares_owned_after_display":"490,883","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-19","filed_date":"2024-03-21","scope":"insider"},{"id":8214072,"accession":"0001193805-23-001470","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-23-001470","line_url":"/filing/0001193805-23-001470#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":18.7203,"price_display":"18.72","price_state":"stated","total_value":93601.5,"total_display":"93,601.50","total_whole":"93,602","shares_owned_after":499448.0,"shares_owned_after_display":"499,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-01","filed_date":"2023-11-03","scope":"insider"},{"id":8018018,"accession":"0001193805-23-001361","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-23-001361","line_url":"/filing/0001193805-23-001361#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.6123,"price_display":"25.61","price_state":"stated","total_value":128061.5,"total_display":"128,061.50","total_whole":"128,062","shares_owned_after":504448.0,"shares_owned_after_display":"504,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-02","filed_date":"2023-10-04","scope":"insider"},{"id":8182398,"accession":"0001193805-23-001249","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-23-001249","line_url":"/filing/0001193805-23-001249#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":31.4527,"price_display":"31.45","price_state":"stated","total_value":157263.5,"total_display":"157,263.50","total_whole":"157,264","shares_owned_after":509448.0,"shares_owned_after_display":"509,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-05","scope":"insider"},{"id":8604970,"accession":"0001193805-23-001075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-23-001075","line_url":"/filing/0001193805-23-001075#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":34.91,"price_display":"34.91","price_state":"stated","total_value":174550.0,"total_display":"174,550.00","total_whole":"174,550","shares_owned_after":514448.0,"shares_owned_after_display":"514,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-03","scope":"insider"},{"id":8182397,"accession":"0001193805-23-001003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-23-001003","line_url":"/filing/0001193805-23-001003#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":35.01,"price_display":"35.01","price_state":"stated","total_value":875250.0,"total_display":"875,250.00","total_whole":"875,250","shares_owned_after":519448.0,"shares_owned_after_display":"519,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-14","filed_date":"2023-07-18","scope":"insider"},{"id":8214071,"accession":"0001193805-23-000955","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-23-000955","line_url":"/filing/0001193805-23-000955#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":28.75,"price_display":"28.75","price_state":"stated","total_value":143750.0,"total_display":"143,750.00","total_whole":"143,750","shares_owned_after":544448.0,"shares_owned_after_display":"544,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-07","scope":"insider"},{"id":7916106,"accession":"0001193805-23-000824","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-23-000824","line_url":"/filing/0001193805-23-000824#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":27.16,"price_display":"27.16","price_state":"stated","total_value":135800.0,"total_display":"135,800.00","total_whole":"135,800","shares_owned_after":549448.0,"shares_owned_after_display":"549,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-01","filed_date":"2023-06-05","scope":"insider"},{"id":8542226,"accession":"0001193805-23-000719","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-23-000719","line_url":"/filing/0001193805-23-000719#line-2","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7925.0,"shares_display":"7,925","price_per_share":30.24,"price_display":"30.24","price_state":"stated","total_value":239652.0,"total_display":"239,652.00","total_whole":"239,652","shares_owned_after":554448.0,"shares_owned_after_display":"554,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-11","filed_date":"2023-05-12","scope":"insider"},{"id":8542221,"accession":"0001193805-23-000719","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-23-000719","line_url":"/filing/0001193805-23-000719#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17075.0,"shares_display":"17,075","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":512250.0,"total_display":"512,250.00","total_whole":"512,250","shares_owned_after":562373.0,"shares_owned_after_display":"562,373","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-10","filed_date":"2023-05-12","scope":"insider"},{"id":8572436,"accession":"0001193805-23-000656","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-23-000656","line_url":"/filing/0001193805-23-000656#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.93,"price_display":"25.93","price_state":"stated","total_value":129650.0,"total_display":"129,650.00","total_whole":"129,650","shares_owned_after":579448.0,"shares_owned_after_display":"579,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-01","filed_date":"2023-05-03","scope":"insider"},{"id":8721954,"accession":"0001193805-23-000516","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-23-000516","line_url":"/filing/0001193805-23-000516#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.38,"price_display":"25.38","price_state":"stated","total_value":126900.0,"total_display":"126,900.00","total_whole":"126,900","shares_owned_after":584448.0,"shares_owned_after_display":"584,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":8390103,"accession":"0001193805-23-000295","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-23-000295","line_url":"/filing/0001193805-23-000295#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.07,"price_display":"16.07","price_state":"stated","total_value":80350.0,"total_display":"80,350.00","total_whole":"80,350","shares_owned_after":589448.0,"shares_owned_after_display":"589,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-08","scope":"insider"},{"id":6293896,"accession":"0001193805-22-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-22-000015","line_url":"/filing/0001193805-22-000015#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8100.0,"shares_display":"8,100","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":324000.0,"total_display":"324,000.00","total_whole":"324,000","shares_owned_after":594448.0,"shares_owned_after_display":"594,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-06","scope":"insider"},{"id":4256150,"accession":"0001193805-21-001784","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-21-001784","line_url":"/filing/0001193805-21-001784#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3633.0,"shares_display":"3,633","price_per_share":40.0021,"price_display":"40.00","price_state":"stated","total_value":145327.6293,"total_display":"145,327.63","total_whole":"145,328","shares_owned_after":602548.0,"shares_owned_after_display":"602,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-16","filed_date":"2021-12-20","scope":"insider"},{"id":5089840,"accession":"0001193805-21-001726","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-21-001726","line_url":"/filing/0001193805-21-001726#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6367.0,"shares_display":"6,367","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":254680.0,"total_display":"254,680.00","total_whole":"254,680","shares_owned_after":606181.0,"shares_owned_after_display":"606,181","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-08","filed_date":"2021-12-10","scope":"insider"},{"id":4819856,"accession":"0001193805-21-001522","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-21-001522","line_url":"/filing/0001193805-21-001522#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":44.41,"price_display":"44.41","price_state":"stated","total_value":444100.0,"total_display":"444,100.00","total_whole":"444,100","shares_owned_after":612548.0,"shares_owned_after_display":"612,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-01","filed_date":"2021-11-03","scope":"insider"},{"id":4551851,"accession":"0001193805-21-001408","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-21-001408","line_url":"/filing/0001193805-21-001408#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":44.36,"price_display":"44.36","price_state":"stated","total_value":443600.0,"total_display":"443,600.00","total_whole":"443,600","shares_owned_after":622548.0,"shares_owned_after_display":"622,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-04","scope":"insider"},{"id":4819853,"accession":"0001193805-21-001272","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-21-001272","line_url":"/filing/0001193805-21-001272#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":55.86,"price_display":"55.86","price_state":"stated","total_value":558600.0,"total_display":"558,600.00","total_whole":"558,600","shares_owned_after":632548.0,"shares_owned_after_display":"632,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-01","filed_date":"2021-09-02","scope":"insider"},{"id":4608880,"accession":"0001193805-21-001112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-21-001112","line_url":"/filing/0001193805-21-001112#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":40.07,"price_display":"40.07","price_state":"stated","total_value":400700.0,"total_display":"400,700.00","total_whole":"400,700","shares_owned_after":642548.0,"shares_owned_after_display":"642,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-05","scope":"insider"},{"id":4819847,"accession":"0001193805-21-000455","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-21-000455","line_url":"/filing/0001193805-21-000455#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":42.95,"price_display":"42.95","price_state":"stated","total_value":429500.0,"total_display":"429,500.00","total_whole":"429,500","shares_owned_after":652548.0,"shares_owned_after_display":"652,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-05","scope":"insider"},{"id":4472452,"accession":"0001193805-21-000323","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-21-000323","line_url":"/filing/0001193805-21-000323#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":54.23,"price_display":"54.23","price_state":"stated","total_value":542300.0,"total_display":"542,300.00","total_whole":"542,300","shares_owned_after":662548.0,"shares_owned_after_display":"662,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":5512422,"accession":"0001193805-21-000124","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-21-000124","line_url":"/filing/0001193805-21-000124#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":75.31,"price_display":"75.31","price_state":"stated","total_value":753100.0,"total_display":"753,100.00","total_whole":"753,100","shares_owned_after":672548.0,"shares_owned_after_display":"672,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-03","scope":"insider"},{"id":4413735,"accession":"0001193805-21-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-21-000014","line_url":"/filing/0001193805-21-000014#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":46.4,"price_display":"46.40","price_state":"stated","total_value":464000.0,"total_display":"464,000.00","total_whole":"464,000","shares_owned_after":682548.0,"shares_owned_after_display":"682,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":2528127,"accession":"0001193805-20-001491","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-20-001491","line_url":"/filing/0001193805-20-001491#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":96.19,"price_display":"96.19","price_state":"stated","total_value":961900.0,"total_display":"961,900.00","total_whole":"961,900","shares_owned_after":692548.0,"shares_owned_after_display":"692,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-01","filed_date":"2020-12-03","scope":"insider"},{"id":2785147,"accession":"0000899243-20-030320","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-030320","line_url":"/filing/0000899243-20-030320#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":55.28,"price_display":"55.28","price_state":"stated","total_value":552800.0,"total_display":"552,800.00","total_whole":"552,800","shares_owned_after":702548.0,"shares_owned_after_display":"702,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-03","scope":"insider"},{"id":2732503,"accession":"0000899243-20-026884","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-026884","line_url":"/filing/0000899243-20-026884#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":42.83,"price_display":"42.83","price_state":"stated","total_value":428300.0,"total_display":"428,300.00","total_whole":"428,300","shares_owned_after":712548.0,"shares_owned_after_display":"712,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-01","filed_date":"2020-10-02","scope":"insider"},{"id":3203275,"accession":"0000899243-20-024363","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-024363","line_url":"/filing/0000899243-20-024363#line-1","is_derivative":false,"issuer_cik":"0001727317","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001727317","owner_cik":"0001727317","owner_name":"Chivukula Pad","owner_display_name":"Chivukula Pad","owner_url":"/insider/0001727317","role":"Officer (Chief Scientific Officer & COO)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":45.16,"price_display":"45.16","price_state":"stated","total_value":451600.0,"total_display":"451,600.00","total_whole":"451,600","shares_owned_after":722548.0,"shares_owned_after_display":"722,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-03","filed_date":"2020-09-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":32,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001768224","name":"Arcturus Therapeutics Holdings Inc.","url":"/issuer/0001768224","role":"Officer (Chief Scientific Officer & COO)","n_filings":31,"first_seen":"2020-09-04","last_seen":"2024-10-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001727317","retrieved_at":"2026-08-25T01:18:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}